未登录 分享 收藏
分享 收藏
分享 收藏
Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction The NRG-BR005 Nonrandomized Clinical Trial 乳腺癌瘤床活检用于预测病理完全缓解:NRG-BR005非随机临床试验 Basik, Mark; Cecchini, Reena S.; de los Santos, Jennifer F.; Umphrey, Heidi R.; Julian, Thomas B.; Mamounas, Eleftherios P.; White, Julia R.; Lucas, Peter C.; Balanoff, Christa R.; Tan, Antoinette R.; Weber, Joseph J.; Edmonson, David A.; Brown-Glaberman, Ursa A.; Diego, Emilia J.; Teshome, Mediget; Matsen, Cindy B.; Seaward, Samantha A.; Wapnir, Irene L.; Wagner, Jamie L.; Tjoe, Judy A.; Thompson, Alastair M.; Wolmark, Norman 分享 收藏
分享 收藏
分享 收藏
Racial Differences in Pathologic Complete Response Rate and Overall Survival Following Neoadjuvant Chemotherapy for Breast Cancer Livasy, Chad; Donahue, Erin; Neelands, Brittany; Hadzikadic-Gusic, Lejla; Sarantou, Terry; Needham, Mckenzie; Patrick, Alicia; Heeke, Arielle; Tan, Antoinette; White, Richard 分享 收藏
MORPHEUS Hormone Receptor-Positive Breast Cancer: interim analysis of a Phase Ib/II, study of fulvestrant ± atezolizumab and abemaciclib triplet treatment in patients metastatic disease Jung, Kyung Hae; Im, Seock-Ah; Yardley, Denise; Hurvitz, Sara; Lee, Keun Seok; Sonnenblick, Amir; Shachar, Shlomit; Tan, Antoinette; Comen, Elizabeth; Gal-Yam, Einav; Brufsky, Adam; Rugo, Hope; Zhu, Jing; DuPree, Kelly; Breton, Vanessa; Young, Fiona; Schwab, Richard; Cha, Edward; Telli, Melinda 分享 收藏
Genomic Landscape of Malignant Phyllodes Tumors Identifies Subsets for Targeted Therapy Bansal, Rani; Adeyelu, Tolulope; Elliott, Andrew; Tan, Antoinette; Meisel, Jane; Oberley, Matthew; Graff, Stephanie; Reis-Filho, Jorge; Sledge, George, Jr.; Sammons, Sarah; Rosenberger, Laura 分享 收藏
Updated results from VERITAC evaluating vepdegestrant, a PROteolysis TArgeting Chimera (PROTAC) estrogen receptor (ER) degrader, in ER- positive/human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer VERITAC评估ER阳性/人表皮生长因子受体2 (HER2) 阴性晚期乳腺癌中蛋白水解靶向嵌合体 (PROTAC) 雌激素受体 (ER) 降解剂vepdegestrant的更新结果 Hurvitz, Sara; Schott, Anne; Ma, Cynthia; Nanda, Rita; Zahrah, George; Hunter, Natasha; Tan, Antoinette; Telli, Melinda; Mesias, Jesus Anampa; Jeselsohn, Rinath; Munster, Pamela; Zhi, Eric; Duperret, Elizabeth; Mather, Cecile; Hamilton, Erika; Han, Hyo 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Vepdegestrant, a proteolysis targeting chimera (PROTAC) estrogen receptor (ER) degrader, in ER plus /human epidermal growth factor receptor 2 (HER2)- advanced breast cancer: Update of dose escalation results from a phase I/II trial Hamilton, E. P.; Han, H.; Schott, A.; Tan, A.; Nanda, R.; Juric, D.; Hunter, N.; Munster, P.; Fang, B.; Zahrah, G.; Ranciato, J.; Gedrich, R.; Zhi, E.; Zhang, Y.; Tan, W.; Mather, C.; Perkins, J.; Anderson, S.; Hurvitz, S. A. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
ARV-471, a PROTAC® estrogen receptor (ER) degrader in advanced ER-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer: phase 2 expansion (VERITAC) of a phase 1/2 study Schott, Anne F.; Hurvitz, Sara; Ma, Cynthia; Hamilton, Erika; Nanda, Rita; Zahrah, George; Hunter, Natasha; Tan, Antoinette R.; Telli, Melinda; Mesias, Jesus Anampa; Jeselsohn, Rinath; Munster, Pamela; Lu, Haolan; Gedrich, Richard; Mather, Cecile; Parameswaran, Janaki; Han, Hyo S. 分享 收藏